Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
—
-1.63%
20%
—
—
40%
—
5 Years
Score—
Net Growth-1.63%
Net Trend20%
Net Income Consistency—
Rev Growth—
Rev Trend40%
Revenue Consistency—
X4 Pharmaceuticals Inc fundamental performance
Across X4 Pharmaceuticals Inc's full reported history, from 2017 to 2025, revenue grew from $ 0.00 to $ 35M and net income went from -$ 33M to -$ 79M. Revenue increased in 33% of the years measured; net income in 22%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 4.29 | — |
1 Year2025-08-12 | $ 2.58 | 66.28% |
5 Years2021-08-12 | $ 169.50 | -97.47% |
All Time2017-11-16 | $ 2.53K | -99.83% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2017-11-16 |
|---|---|---|---|---|
| Price | $ 4.29 | $ 2.58 | $ 169.50 | $ 2.53K |
| Return | — | 66.28% | -97.47% | -99.83% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 15M | -$ 90M | $ 207M |
| 2025 | $ 35M | -$ 79M | $ 252M |
| 2024 | $ 2M | -$ 37M | $ 102M |
| 2023 | $ 0.00 | -$ 101M | $ 114M |
| 2022 | $ 0.00 | -$ 93M | $ 121M |
| 2021 | $ 0.00 | -$ 88M | $ 81M |
| 2020 | $ 3M | -$ 62M | $ 78M |
| 2019 | $ 3M | -$ 52M | $ 126M |
| 2018 | $ 3M | -$ 33M | $ 30M |
| IPO2017 | $ 0.00 | -$ 33M | $ 76M |
Explore beyond XFOR
You're looking at X4 Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
